Posted on September 15th, 2008
Breast cancer will afflict one of every eight American women in her lifetime.
A pharmacologist doing cutting-edge research on separating normal and cancer cells will discuss her work in this area at the second Suter Science Seminar of fall semester.
Dr. Jeannine Strobl
Jeannine Strobl, professor and pharmacology chair at Edward Via Virginia College of Osteopathic Medicine, Blacksburg, will speak 4 p.m. Monday, Sept. 22 in room 104 of the Suter Science Center on “Cells and Bridges: Can Microengineering Help Identify Metastatic Cancer Cells?”
“We are using microengineering to refine the chip design and optimize the separation of normal and metastatic breast cancer cells, Dr. Strobl said. “This technology can be applied to the development of microchip systems for early detection of metastatic breast cancer cells and screening platforms to identify drugs that suppress metastatic behavior in cancer cells.”
“Dr. Strobl has had a long and successful research program over the past years investigating factors and influences that cause and promote cancer, especially breast cancer,” said Roman J. Miller, professor of biology at EMU. “Health care professionals, health science students, nurses and other persons who are interested in the causes and potential treatments for breast cancer are especially encouraged to attend this seminar presentation,” Dr. Miller added.
Read more about Dr. Stobl’s presentation on cancer research.
The seminar series is sponsored by the Daniel B. Suter Endowment. Dr. Suter joined the EMU science faculty in 1948 and became head of the biology department and developed the pre-med program. He retired in 1985 and died in 2006.
Refreshments will be served 15 minutes prior to the presentation.
Admission to the program is free. For more information, contact Roman J. Miller, 540-432-4412 or email@example.com.